Hepatobiliary and Pancreatic (HPB) Surgery: Current Status and Future Perspectives

Dear Colleagues,

Hepatobiliary and pancreatic (HPB) surgery is used to treat various diseases, ranging from benign conditions to primary and secondary neoplasms. In the last two decades, important advances in surgical care have led to significant reductions in peri-operative morbidity and mortality, with considerable benefits in this rapidly growing field of surgery. Considerable improvements in surgical techniques, mainly represented by the expansion of minimally invasive methods, particularly robotic-assisted approaches, and in the applications of novel technologies, such as the implementation of artificial intelligence and augmented reality, have led to promising results, providing HPB patients with optimal diagnostic, therapeutic and prognostic tools for achieving the best possible outcomes.

Other approaches that have been successfully adopted for many years with demonstrated important benefits have recently undergone relevant improvements, i.e., the use of indocyanine green during hepatobiliary surgery for the identification of bile ducts and subcapsular hepatic tumors or the precise demarcation of hepatic segments, increasing the accuracy and safety of open and minimally invasive hepatic resections.

We invite you to submit a paper to this Special Issue, which will explore the most recent progress regarding HPB surgery. Both clinical and technological evolutions will be considered with the option of including narrative and systematic reviews, meta-analysis, research articles and case reports of particular interest or exceptional didactical value.

“Hepatobiliary and Pancreatic (HPB) Surgery: Current Status and Future Perspectives” will give specialists involved in the care of HPB surgical patients the opportunity to share their experiences or points of view on several relevant topics, with the primary aim being improving global knowledge and patient outcomes.

We look forward to receiving your contributions.

Dr. Andrea Benedetti Cacciaguerra
Dr. Paolo Vincenzi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.